Article

New Therapeutic Targets in Vitiligo

2024-07-09

Abstract excerpt

Vitiligo is a chronic autoimmune disease characterized by progressive depigmentation of the skin caused by the selective destruction of melanocytes. Although its etiopathogenesis remains unclear, multiple factors are believed to be involved, including genetic and metabolic factors linked to cellular oxidative stress, melanocyte adhesion defects, innate and adaptive immunity. The aim of this review is to provide an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1d736485-877d-5f48-a147-ca5f40307bc5
DOI: 10.20944/preprints202407.0700.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

New Therapeutic Targets in VitiligoDOI 10.20944/preprints202407.0700.v1Read

Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.Semantic proximity Read

Vitiligo: Mechanisms of Pathogenesis and TreatmentSemantic proximity Read

Recent advances in understanding vitiligoSemantic proximity Read

Vitiligo: pathogenetic hypotheses and targets for current therapies.Semantic proximity Read

Vitiligo: current medical and scientific understanding.Semantic proximity Read

Novel immunological and genetic factors associated with vitiligo: A reviewSemantic proximity Read

Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective.Semantic proximity Read

Etiopathogenesis and Emerging Methods for Treatment of VitiligoSemantic proximity Read

Vitiligo: interplay between oxidative stress and immune system.Semantic proximity Read

Vitiligo--part 1.Semantic proximity Read

Translational Research in Vitiligo.Semantic proximity Read

Immunometabolism in the pathogenesis of vitiligoSemantic proximity Read